MedPath

Methylprednisolone sodium succinate

Approved
Approval ID

738753c7-507d-4881-5194-02dd7597768b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 11, 2022

Manufacturers
FDA

Dr. Reddy's Laboratories Inc

DUNS: 802315887

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Methylprednisolone sodium succinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-127
Application NumberANDA212396
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methylprednisolone sodium succinate
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 11, 2022
FDA Product Classification

INGREDIENTS (4)

METHYLPREDNISOLONE SODIUM SUCCINATEActive
Quantity: 40 mg in 1 mL
Code: LEC9GKY20K
Classification: ACTIM
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Quantity: 1.84 mg in 1 mL
Code: 593YOG76RN
Classification: IACT
LACTOSE MONOHYDRATEInactive
Quantity: 25 mg in 1 mL
Code: EWQ57Q8I5X
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Quantity: 17.46 mg in 1 mL
Code: 22ADO53M6F
Classification: IACT

Methylprednisolone sodium succinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-129
Application NumberANDA212396
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methylprednisolone sodium succinate
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 11, 2022
FDA Product Classification

INGREDIENTS (3)

METHYLPREDNISOLONE SODIUM SUCCINATEActive
Quantity: 125 mg in 2 mL
Code: LEC9GKY20K
Classification: ACTIM
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Quantity: 17.4 mg in 2 mL
Code: 22ADO53M6F
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Quantity: 1.84 mg in 2 mL
Code: 593YOG76RN
Classification: IACT

Methylprednisolone sodium succinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-130
Application NumberANDA212396
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methylprednisolone sodium succinate
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 11, 2022
FDA Product Classification

INGREDIENTS (3)

SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Quantity: 14.72 mL in 16 mL
Code: 593YOG76RN
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Quantity: 139.2 mg in 16 mL
Code: 22ADO53M6F
Classification: IACT
METHYLPREDNISOLONE SODIUM SUCCINATEActive
Quantity: 1 g in 16 mL
Code: LEC9GKY20K
Classification: ACTIM

Methylprednisolone sodium succinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-128
Application NumberANDA212396
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methylprednisolone sodium succinate
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 11, 2022
FDA Product Classification

INGREDIENTS (3)

METHYLPREDNISOLONE SODIUM SUCCINATEActive
Quantity: 500 mg in 8 mL
Code: LEC9GKY20K
Classification: ACTIM
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Quantity: 7.36 mg in 8 mL
Code: 593YOG76RN
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Quantity: 69.6 mg in 8 mL
Code: 22ADO53M6F
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.